Siguler Guff Advisers, LLC Royalty Pharma PLC Transaction History
Siguler Guff Advisers, LLC
- $208 Million
- Q4 2022
A detailed history of Siguler Guff Advisers, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Siguler Guff Advisers, LLC holds 3,391,754 shares of RPRX stock, worth $133 Million. This represents 64.43% of its overall portfolio holdings.
Number of Shares
3,391,754
Previous 3,391,754
-0.0%
Holding current value
$133 Million
Previous $134 Million
-0.0%
% of portfolio
64.43%
Previous 70.27%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
536Shares Held
303MCall Options Held
1.34MPut Options Held
252K-
Morgan Stanley New York, NY44.2MShares$1.73 Billion0.1% of portfolio
-
Capital International Investors Los Angeles, CA27.2MShares$1.07 Billion0.16% of portfolio
-
Black Rock Inc. New York, NY23MShares$901 Million0.01% of portfolio
-
Baillie Gifford & CO17.4MShares$680 Million0.48% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$478 Million0.45% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $17.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...